ALCAM is a biomarker of tumor aggressiveness and worse prognosis in glottic laryngeal squamous cell carcinoma.
Pedro Nicolau NetoBernardo Cacciari PeryassúFlávia Nascimento de CarvalhoPaulo Thiago Souza-SantosPriscila ValverdeCristina Moreira NascimentoIzabella CostaFernando L DiasLuis Felipe Ribeiro PintoPublished in: Head & neck (2024)
High ALCAM expression was associated with an aggressive glottic LSCC profile.